Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
企業コードEKSO
会社名Ekso Bionics Holdings Inc
上場日Apr 10, 2013
最高経営責任者「CEO」Davis (Scott G)
従業員数61
証券種類Ordinary Share
決算期末Apr 10
本社所在地101 Glacier Point
都市SAN RAFAEL
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94901
電話番号15109841761
ウェブサイトhttps://eksobionics.com/
企業コードEKSO
上場日Apr 10, 2013
最高経営責任者「CEO」Davis (Scott G)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし